IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	190.67	198.85	126.94	91.98
Other Operating Expenses	-430.41	3.04	1.85	-8.46
Total Operating Expenses	-239.74	201.9	128.78	83.53
Operating Income	239.74	-201.9	-128.78	-83.53
Interest Expense	-1.09	-1.09	-	-
Interest & Investment Income	-3.9	114.12	-	-
Currency Exchange Gain (Loss)	1.52	0.36	-2.3	-0.15
Other Non-Operating Income	-135.74	-204.72	-47.55	-51.63
EBT Excluding Unusual Items	100.53	-293.23	-178.63	-135.31
Gain (Loss) on Sale of Investments	123.16	175.76	12.76	-
Asset Writedown	841.78	909.18	1,478	747.19
Pretax Income	1,065	791.71	1,313	611.88
Income Tax Expense	-696.02	462.95	-	-
Net Income	1,761	328.76	1,313	611.88
Net Income to Common	1,761	328.76	1,313	611.88
Net Income Growth	5669.96%	-74.95%	114.51%	-
Basic Shares Outstanding	-	168	168	70
Diluted Shares Outstanding	-	168	168	70
Shares Change (YoY)	-	-	139.29%	-
EPS (Basic)	-	1.96	7.84	8.74
EPS (Diluted)	-	1.96	7.84	8.74
EPS Growth	-	-74.95%	-10.36%	-
EBITDA	241.75	-200.23	-128.13	-83.47
D&A For Ebitda	2.01	1.67	0.65	0.05
EBIT	239.74	-201.9	-128.78	-83.53
Effective Tax Rate	-	58.48%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.